Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tamara, Mucenic"'
Autor:
Raj Punwaney, Sandra V. Navarra, Amy Pierce, Saira Z Sheikh, Ricardo Acayaba de Toledo, Josep Ordi Ros, Roger A. Levy, Ignacio García-De La Torre, Jorge Alfonso Ross Terres, James Cheng-Chung Wei, David M. Roth, Morton Scheinberg, Beulah Ji, Mercedes A. García, Julia Harris, Damon Bass, Alireza Nami, Tamara Mucenic, D. Tegzova, Kevin S. Thorneloe, Kathleen Maksimowicz-McKinnon, Mauricio R Abello Banfi, William Stohl, Carlos Abud-Mendoza
Publikováno v:
The Lancet Rheumatology. 3:e122-e130
Summary Background Belimumab is approved for the treatment of active systemic lupus erythematosus (SLE). Although clinical trials showed a favourable benefit–risk profile, numerical differences in the incidence of mortality and adverse events of sp
Publikováno v:
Revista Brasileira de Reumatologia, Vol 49, Iss 3, Pp 276-287 (2009)
CD55 e CD59 são proteínas de membrana ancoradas por glicosilfosfatidilinositol que apresentam propriedades reguladoras da ativação da cascata do complemento. Essa regulação ocorre através da inibição da C3 convertase pelo CD55 e prevenção
Externí odkaz:
https://doaj.org/article/af50bdf5e53b4a51a4dcded54c54edf5
Autor:
A. Liu, S. Muzaffar, Regina Kurrasch, James Cheng-Chung Wei, Tamara Mucenic, Morton Scheinberg, Saira Z Sheikh, S. Fernandes, Rajesh Punwaney, N.L. Fox, H. Quasny, William Stohl, Julia Harris, D. Tegzova, David M. Roth
Publikováno v:
Annals of the Rheumatic Diseases. 80:1170-1171
Background:Belimumab (BEL), a recombinant human monoclonal antibody that inhibits B-lymphocyte stimulator (BLyS), is approved for the treatment of systemic lupus erythematosus (SLE). Clinical studies have yielded varying incidence rates of mortality
Autor:
David M. Roth, Damon Bass, Saira Z Sheikh, James Cheng-Chung Wei, Morton Scheinberg, William Stohl, Kevin S. Thorneloe, D. Tegzova, Rajesh Punwaney, Julia Harris, Roger A. Levy, Jorge Alfonso Ross Terres, Beulah Ji, Tamara Mucenic
Publikováno v:
Oral Presentations.
Background Belimumab (BEL) is approved in adults with active, autoantibody-positive SLE. Phase 2, 3 and long-term extension studies showed a favourable benefit-risk profile. However, numerical differences in the incidence of mortality, infections, hy
Autor:
Tamara Mucenic, Ricardo Machado Xavier, Odirlei André Monticielo, José Artur Bogo Chies, Camila Rosat Consiglio, João Carlos Tavares Brenol, Tiago Degani Veit
Publikováno v:
Tissue Antigens. 77:540-545
Systemic lupus erythematosus (SLE) is an inflammatory autoimmune disease that affects several organs and systems. Its etiology remains unknown, although it is probably multifactorial. The human leukocyte antigen G (HLA-G) is a nonclassic major histoc
Autor:
Gustavo Adolpho Moreira Faulhaber, Lucia Mariano da Rocha Silla, Jóice Merzoni, Tamara Mucenic, Ana Paula Alegretti, Ricardo Machado Xavier
Publikováno v:
Cellular Immunology. 265:127-132
CD55 and CD59 are glycosylphosphatidylinositol-anchored proteins with complement inhibitory properties. CD55 inhibits the formation of C3 convertases, and CD59 prevents the terminal polymerisation of the membrane attack complex. It has been reported
Autor:
J M Z Júnior, José Artur Bogo Chies, Tamara Mucenic, G G Rucatti, Ricardo Machado Xavier, G.K. da Silva, Nadine Glesse, Odirlei André Monticielo, João Carlos Tavares Brenol, B P dos Santos
Publikováno v:
Lupus. 19:280-287
The mannose-binding lectin gene (MBL-2) has emerged as a candidate for systemic lupus erythematosus susceptibility, but studies in Brazilian population have not been conducted. To examine potential associations of mannose-binding lectin alleles G57E,
Autor:
Marion Schiengold, Tamara Mucenic, José Artur Bogo Chies, Tatiana Pereira Gonzalez, Ricardo Machado Xavier, João Carlos Tavares Brenol
Publikováno v:
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
P-glycoprotein (Pgp), the ABCB1 gene product, acts as an efflux pump that transports a large variety of substrates and is a mechanism of cell protection against xenobiotics. An increasing number of studies have shown that some ABCB1 polymorphisms may
Autor:
Betânia Câmara-Ehlers, Osvaldo J. M. Nascimento, Marcia Lorena Fagundes Chaves, Pedro Schestatsky, Michael I. Bennett, Wolnei Caumo, Tamara Mucenic, Vitor Félix-Torres
Publikováno v:
Pain medicine (Malden, Mass.). 12(10)
Background. Neuropathic pain (NP) is a very fre- quent and unrecognized condition in clinical prac- tice. Therefore, it is important to have a reliable instrument to assess pain subtypes in various cultures. The Leeds Assessment of Neuropathic Sympto
Publikováno v:
Revista Brasileira de Reumatologia v.49 n.3 2009
Revista Brasileira de Reumatologia
Sociedade Brasileira de Reumatologia (SBR)
instacron:SBR
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Revista Brasileira de Reumatologia, Volume: 49, Issue: 3, Pages: 276-287, Published: JUN 2009
Revista Brasileira de Reumatologia
Sociedade Brasileira de Reumatologia (SBR)
instacron:SBR
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Revista Brasileira de Reumatologia, Volume: 49, Issue: 3, Pages: 276-287, Published: JUN 2009
CD55 e CD59 são proteínas de membrana ancoradas por glicosilfosfatidilinositol que apresentam propriedades reguladoras da ativação da cascata do complemento. Essa regulação ocorre através da inibição da C3 convertase pelo CD55 e prevenção
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5446e3996e6e92fc13f05e0225833f67
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042009000300009
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042009000300009